 |
Welcome, Introduction, and Program Overview
Steven Fishbane, MD
|
 |
Hb Stability, IV Iron, and ESA: What We Know
Suzann VanBuskirk, BSN, RN, CNN |
 |
Recent Guidance From KDOQI, FDA, and CMS on Hb Targets and Anemia Management
Steven Fishbane, MD
|
 |
Balancing IV Iron and ESA Therapy to Avoid Hb Variability:
Case Studies
Kristin Larson, RN, ANP, GNP, CNN |
 |
Panel Discussion
Steven Fishbane, Suzann VanBuskirk, Kristin Larson |
At the conclusion of the certified activity, participants should be able to do the following:
 |
Provide a basic understanding on the importance of stabilizing Hb levels and the need to balance IV iron and ESA therapy in anemia management in hemodialysis patients
|
 |
Examine recent guidance proposed by KDOQI, FDA, and CMS on appropriate Hb targets and anemia management
|
 |
Describe case studies using best practices for IV iron and ESA therapy to help clinicians avoid, anticipate, and minimize Hb variability
|
|
Steven Fishbane, MD
Chief of Nephrology
Winthrop-University Hospital
Mineola, New York
Suzann VanBuskirk, BSN, RN, CNN
Independent Consultant
Elkton, Maryland
Kristin Larson, RN, ANP, GNP, CNN
Renal Consultant
Salt Lake City, Utah
|
|
 |
This activity
has been planned and produced in accordance with
CE guidelines and policies. From a CE symposium
held in April 2008 at the American Nephrology
Nurses' Association (ANNA) National Symposium in Philadelphia, PA.
This activity provides 1.5 contact hours.
The American Nephrology Nurses’ Association (ANNA) is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a Provider approved by the California Board of Registered Nursing, provider number CEP 00910 for 1.5 contact hours.
|
|
Posting Date: September 15, 2008
CE Credit Eligible
Through: September 15, 2010
CE Credit Hours/Completion Time: 1.5
Target Audiences: Nephrology nurses and technicians.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the post-test, read
the linked abstracts in the post-test answer feedback material. |
 |
SPEAKER DISCLOSURE STATEMENT: |
See individual talks.
This ANNA Satellite symposium was developed by ANNA and sponsored by an educational grant from Watson Nephrology.
ANNA and HDCN CE POLICY
STATEMENTS: |
The CE policy and disclosure statements of the American Nephrology Nurses' Association
are given in detail on the Symposium
Home Page. The CE policy statements of HDCN are
listed on this page. |
|